 |
|
|
| |
Abbvie IFN-free 3 DAA Regimen in HCV Genotype 1-infected Pati ents on Methadone or Buprenorphine
|
| |
| |
Reported by Jules Levin
Presented at the 21st Annual Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, Massachusetts
Jacob Lalezari1, J Greg Sullivan2, Vinod Rustgi3, Humberto Aguilar4, Franco Felizarta5, Daniel Cohen6
1Quest Clinical Research, San Francisco, California, United States; 2Parkway Medical Center, Birmingham, Alabama, United States; 3Metropolitan Research, Fairfax, Virginia, United States; 4Louisiana Research Center, LLC, Shreveport, Louisiana, United States; 5Private practi ce, Bakersfi eld, California, United States; 6AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
